See more : B-RIGHT REALESTATE LIMITED (BRRL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of PANJON LTD. (PANJON.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PANJON LTD., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- eLand Information Co., Ltd (6925.TWO) Income Statement Analysis – Financial Results
- Danske Bank A/S (DNSKF) Income Statement Analysis – Financial Results
- Ipek Dogal Enerji Kaynaklari Arastirma ve Üretim A.S. (IPEKE.IS) Income Statement Analysis – Financial Results
- Bioservo Technologies AB (publ) (BIOS.ST) Income Statement Analysis – Financial Results
- Hangzhou Zhongtai Cryogenic Technology Corporation (300435.SZ) Income Statement Analysis – Financial Results
PANJON LTD. (PANJON.BO)
About PANJON LTD.
Panjon Ltd. engages in manufacturing and trading of Allopathic and Ayurvedic medicines. Its products include tablet, balm, inhaler, cough drops, and Swad and Swad Chatpati digestive drops. The company was founded by Nagin Bhai Kothari in 1964 and is headquartered in Indore, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 125.52M | 60.91M | 84.32M | 145.39M | 264.26M | 200.98M | 139.83M | 122.62M | 194.76M | 193.12M | 188.33M |
| Cost of Revenue | 91.74M | 20.81M | 44.91M | 117.58M | 235.24M | 183.83M | 125.59M | 106.52M | 206.09M | 179.38M | 157.54M |
| Gross Profit | 33.78M | 40.10M | 39.41M | 27.81M | 29.01M | 17.15M | 14.25M | 16.10M | -11.32M | 13.74M | 30.79M |
| Gross Profit Ratio | 26.91% | 65.83% | 46.74% | 19.13% | 10.98% | 8.53% | 10.19% | 13.13% | -5.81% | 7.11% | 16.35% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.33M | 2.13M | 4.83M | 1.51M | 1.65M | 3.44M | 3.64M | 3.74M | 50.00K | 1.32M | 1.40M |
| Selling & Marketing | 0.00 | 24.41M | 22.08M | 12.45M | 12.85M | 903.13K | 1.48M | 1.84M | 3.05M | 1.54M | 15.63M |
| SG&A | 1.33M | 26.54M | 26.91M | 13.96M | 14.50M | 4.34M | 5.12M | 5.59M | 5.50M | 11.12M | 28.04M |
| Other Expenses | 32.45M | 3.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 33.78M | 42.25M | 39.46M | 27.96M | 28.48M | 15.77M | 15.31M | 17.14M | 35.63M | 12.80M | 29.76M |
| Cost & Expenses | 125.52M | 63.07M | 84.37M | 145.54M | 263.73M | 199.59M | 140.89M | 123.66M | 241.72M | 192.18M | 187.30M |
| Interest Income | 0.00 | 3.82M | 2.97M | 3.27M | 2.90M | 1.06M | 2.89M | 1.28M | 129.73K | 184.30K | 306.80K |
| Interest Expense | 346.00K | 469.96K | 637.69K | 979.27K | 1.50M | 211.32K | 31.70K | 20.53K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.17M | 2.11M | 2.03M | 2.25M | 2.73M | 1.07M | 1.31M | 1.42M | 1.25M | 816.64K | 892.50K |
| EBITDA | 4.09M | -66.39K | -40.45M | 1.89M | 6.10M | 2.43M | -843.84K | -1.25M | -30.36M | 1.79M | 1.97M |
| EBITDA Ratio | 3.26% | 6.17% | 5.61% | 3.55% | 2.31% | 1.21% | -0.60% | -1.02% | -15.59% | 0.93% | 1.05% |
| Operating Income | 17.64M | 1.65M | 2.70M | 2.90M | 3.37M | 1.36M | -2.15M | -2.67M | -31.61M | 971.02K | 1.08M |
| Operating Income Ratio | 14.05% | 2.71% | 3.20% | 2.00% | 1.28% | 0.68% | -1.54% | -2.18% | -16.23% | 0.50% | 0.57% |
| Total Other Income/Expenses | -16.07M | -21.07M | -42.85M | -16.65M | 1.34M | 1.07M | -7.30M | -10.27M | -30.26M | -216.20K | -355.38K |
| Income Before Tax | 1.57M | 1.18M | -40.15M | 1.92M | 1.87M | 2.44M | 1.83M | 247.09K | -47.08M | 754.82K | 724.02K |
| Income Before Tax Ratio | 1.25% | 1.93% | -47.61% | 1.32% | 0.71% | 1.21% | 1.31% | 0.20% | -24.18% | 0.39% | 0.38% |
| Income Tax Expense | 0.00 | -6.92M | 1.37M | 962.37K | 2.19M | 1.22M | 670.53K | 3.36M | 12.77M | 2.50M | 101.73K |
| Net Income | 1.51M | 8.10M | -41.52M | 962.49K | -321.38K | 1.22M | 1.16M | 3.61M | -34.31M | -1.75M | 622.28K |
| Net Income Ratio | 1.21% | 13.30% | -49.24% | 0.66% | -0.12% | 0.61% | 0.83% | 2.94% | -17.62% | -0.91% | 0.33% |
| EPS | 0.10 | 0.52 | -2.68 | 0.06 | -0.02 | 0.08 | 0.07 | 0.23 | -2.21 | -0.11 | 0.06 |
| EPS Diluted | 0.10 | 0.52 | -2.68 | 0.06 | -0.02 | 0.08 | 0.07 | 0.23 | -2.21 | -0.11 | 0.06 |
| Weighted Avg Shares Out | 15.52M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.48M | 10.55M |
| Weighted Avg Shares Out (Dil) | 15.52M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 15.50M | 10.48M |
No news found for: PANJON.BO
Source: https://incomestatements.info
Category: Stock Reports